LogiPharma Europe 2025: Inside the Daily Workflow of Sanofi’s Global Supply Chain Head

Ruth Beadle, head, global supply chain, Sanofi, explains how the company balances daily operations with long-term transformation efforts to ensure timely delivery of critical medications to patients.

PC: As the head of global supply chain, what does your day-to-day workflow typically consist of?

Beadle: Our primary responsibility is getting products to patients—that’s at the heart of what we do. Every day, I focus on identifying potential challenges and working with my team to mitigate risks, ensuring patients receive the medications they need to improve their lives.

At the same time, Sanofi is undergoing a significant transformation as we modernize our operations. A large part of my day is spent executing our current strategic plans and assessing initiatives for the next three to four years. I also devote time to engaging externally—at events like this one or industry roundtables—as well as internally, because you never know where the next great idea might come from.

Full Interview Summary: Sanofi is in the midst of a significant digital transformation, with the goal of becoming the first biopharma company powered by AI at scale. A major component of that vision is building a “smart supply chain”—an end-to-end, data-driven, and digitally enabled system that provides visibility from suppliers all the way to patients. This transformation has already led to measurable results, including a 12% improvement in service levels and a 14-point gain in cost-to-serve efficiency. By eliminating outdated Excel-based workflows and implementing advanced planning and ERP systems, Sanofi has increased visibility and responsiveness across its operations.

Sustainability is another major focus. Sanofi aims to be carbon neutral by 2030 and achieve net-zero greenhouse gas emissions by 2045. Compared to 2019 levels, the company has already reduced Scope 1 and 2 emissions by 47% and Scope 3 emissions by 10%. To reach these goals, Sanofi is shifting away from air freight—used only when life-saving products require it—and investing more in sea and rail transport. The company has even piloted shipments using sailing vessels to further reduce its environmental footprint.

Reflecting on the event, Beadle highlighted the value of engaging with peers across the industry. Sessions on reimagining operations and sustainability reinforced Sanofi’s direction, while also prompting her to consider how the company can continue accelerating progress and adapting in a rapidly evolving healthcare landscape.